Healthy Dialogue

Latest Episodes:

Updated Pediatric Sepsis Criteria—Transitioning From SIRS to Phoenix Feb 27, 2024

Show notes

JAMA Associate Editor Romain Pirracchio, MD, MPH, discusses context and implications of the new pediatric sepsis criteria with authors Hallie Prescott, MD, MSc, of the University of Michigan and Ann Arbor VA Hospital, and Roberto Jabornisky, MD, of Northeastern National Medical School in Argentina. Related Content:

Renter Eviction, Excess Mortality, and COVID-19 Feb 20, 2024

Show notes

Renters who received eviction filings experienced excess mortality associated with the COVID-19 pandemic. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses a recent study that underscores the importance of studying health outcomes among marginalized populations with author Nick Graetz, PhD, from Princeton University. Related Content:

Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction

Azithromycin to Prevent Childhood Mortality in Sub-Saharan Africa Feb 13, 2024

Show notes

Childhood death rates remain high in some areas of sub-Saharan Africa, despite global reductions in childhood mortality. JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Thomas Lietman, MD, University of California, San Francisco, discuss twice-yearly azithromycin to reduce childhood mortality. Related Content:

Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents Feb 06, 2024

Show notes

Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years

Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision Jan 23, 2024

Show notes

Following the Dobbs decision, females aged 18-45 years living in states with "trigger laws" that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA Associate Editor Donald Goff, MD, speaks with editorialist Julia Steinberg, PhD, associate professor at the School of Public Health at the University of Maryland, about this topic. Related Content:

Patient-Centered Palliative Care Jan 16, 2024

Show notes

JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Alexander K. Smith, MD, MS, MPH, University of California, San Francisco, discuss the importance of 2 new palliative care trials that were recently published in JAMA. Related Content:

Dialysis Facility Performance and Social Risk in the First Year of the ESRD Treatment Choices Model Jan 09, 2024

Show notes

Dialysis facilities in the US are financially rewarded for higher rates of home dialysis and kidney transplant, but facilities that serve patients with high social risk might have a harder time meeting these goals. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, speaks with Amal N. Trivedi, MD, MPH, of Brown University, about how this plays out under the ESRD Treatment Choices Model. Related Content:

Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices Model

Alpha-Gal Syndrome Jan 02, 2024

Show notes

Alpha-gal syndrome is a food allergy to red meat products that develops after affected individuals are bitten by a tick. JAMA Deputy Editor Kristin Walter, MD, MS, discusses alpha-gal syndrome with author Mariel R. Benjamin, MD, assistant professor in the Division of Allergy and Clinical Immunology at Michigan Medicine. Related Content:

What Is Alpha-Gal Syndrome?

Private Equity Acquisition and Hospital-Acquired Adverse Events in the US Dec 26, 2023

Show notes

The effects of private equity acquisition of US hospitals on the quality of inpatient care and patient outcomes remain largely unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, spoke with author Zirui Song, MD, PHD, of Massachusetts General Hospital, about a recent study showing that private equity acquisition was associated with increased hospital-acquired adverse events. Related Content:

Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition

Effect of Dietary Sodium on Blood Pressure Dec 19, 2023

Show notes

Does reducing dietary sodium benefit patients already taking antihypertensive medication? JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Norrina Allen, PhD, MPH, from Northwestern University, about the effect of dietary sodium on blood pressure. Related Content:

Effect of Dietary Sodium on Blood Pressure

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected